1
|
Dragostin I, Dragostin OM, Iacob AT, Dragan M, Chitescu CL, Confederat L, Zamfir AS, Tatia R, Stan CD, Zamfir CL. Chitosan Microparticles Loaded with New Non-Cytotoxic Isoniazid Derivatives for the Treatment of Tuberculosis: In Vitro and In Vivo Studies. Polymers (Basel) 2022; 14:polym14122310. [PMID: 35745886 PMCID: PMC9230020 DOI: 10.3390/polym14122310] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2022] [Revised: 06/04/2022] [Accepted: 06/05/2022] [Indexed: 02/01/2023] Open
Abstract
Lately, in the world of medicine, the use of polymers for the development of innovative therapies seems to be a major concern among researchers. In our case, as a continuation of the research that has been developed so far regarding obtaining new isoniazid (INH) derivatives for tuberculosis treatment, this work aimed to test the ability of the encapsulation method to reduce the toxicity of the drug, isoniazid and its new derivatives. To achieve this goal, the following methods were applied: a structural confirmation of isoniazid derivatives using LC-HRMS/MS; the obtaining of microparticles based on polymeric support; the determination of their loading and biodegradation capacities; in vitro biocompatibility using MTT cell viability assays; and, last but not least, in vivo toxicological screening for the determination of chronic toxicity in laboratory mice, including the performance of a histopathological study and testing for liver enzymes. The results showed a significant reduction in tissue alterations, the disappearance of cell necrosis and microvesicular steatosis areas and lower values of the liver enzymes TGO, TGP and alkaline phosphatase when using encapsulated forms of drugs. In conclusion, the encapsulation of INH and INH derivatives with chitosan had beneficial effects, suggesting a reduction in hepatotoxicity and, therefore, the achievement of the aim of this paper.
Collapse
Affiliation(s)
- Ionut Dragostin
- Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, Dunarea de Jos University, 35 Al. I. Cuza Str., 800017 Galati, Romania
| | - Oana-Maria Dragostin
- Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, Dunarea de Jos University, 35 Al. I. Cuza Str., 800017 Galati, Romania
| | - Andreea Teodora Iacob
- Faculty of Pharmacy, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| | - Maria Dragan
- Faculty of Pharmacy, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| | - Carmen Lidia Chitescu
- Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, Dunarea de Jos University, 35 Al. I. Cuza Str., 800017 Galati, Romania
| | - Luminita Confederat
- Faculty of Medicine, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| | - Alexandra-Simona Zamfir
- Department of Pneumology, Faculty of Medicine, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| | - Rodica Tatia
- Department of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, 060031 Bucharest, Romania
| | - Catalina Daniela Stan
- Faculty of Pharmacy, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| | - Carmen Lacramioara Zamfir
- Department of Histology, Faculty of Medicine, University of Medicine and Pharmacy Grigore T. Popa, 16 Universitatii Str., 700115 Iasi, Romania
| |
Collapse
|
2
|
Johansen MD, Shalini, Kumar S, Raynaud C, Quan DH, Britton WJ, Hansbro PM, Kumar V, Kremer L. Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2021; 65:e0001121. [PMID: 33972252 PMCID: PMC8284457 DOI: 10.1128/aac.00011-21] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 05/04/2021] [Indexed: 11/20/2022] Open
Abstract
Tuberculosis remains a leading cause of mortality among infectious diseases worldwide, prompting the need to discover new drugs to fight this disease. We report here the design, synthesis, and antimycobacterial activity of isatin-mono/bis-isoniazid hybrids. Most of the compounds exhibited very high activity against Mycobacterium tuberculosis, with MICs in the range of 0.195 to 0.39 μg/ml, and exerted a more potent bactericidal effect than the standard antitubercular drug isoniazid (INH). Importantly, these compounds were found to be well tolerated at high doses (>200 μg/ml) on Vero kidney cells, leading to high selectivity indices. Two of the most promising hybrids were evaluated for activity in THP-1 macrophages infected with M. tuberculosis, among which compound 11e was found to be slightly more effective than INH. Overexpression of InhA along with cross-resistance determination of the most potent compounds, selection of resistant mutants, and biochemical analysis, allowed us to decipher their mode of action. These compounds effectively inhibited mycolic acid biosynthesis and required KatG to exert their biological effects. Collectively, this suggests that the synthesized isatin-INH hybrids are promising antitubercular molecules for further evaluation in preclinical settings.
Collapse
Affiliation(s)
- Matt D. Johansen
- Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
- Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia
| | - Shalini
- Department of Chemistry, Guru Nanak Dev University, Punjab, India
| | - Sumit Kumar
- Department of Chemistry, Guru Nanak Dev University, Punjab, India
| | - Clément Raynaud
- Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
| | - Diana H. Quan
- Tuberculosis Research Program, Centenary Institute, The University of Sydney, Camperdown, NSW, Australia
| | - Warwick J. Britton
- Centenary Institute, The University of Sydney, Camperdown, NSW, Australia
- Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - Philip M. Hansbro
- Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia
| | - Vipan Kumar
- Department of Chemistry, Guru Nanak Dev University, Punjab, India
| | - Laurent Kremer
- Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
- INSERM, IRIM, Montpellier, France
| |
Collapse
|
3
|
Rani A, Johansen MD, Roquet-Banères F, Kremer L, Awolade P, Ebenezer O, Singh P, Sumanjit, Kumar V. Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials. Bioorg Med Chem Lett 2020; 30:127576. [PMID: 32980514 DOI: 10.1016/j.bmcl.2020.127576] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 09/19/2020] [Accepted: 09/21/2020] [Indexed: 12/20/2022]
Abstract
A series of 4-aminoquinoline-isoindoline-dione-isoniazid triads were synthesized and assessed for their anti-mycobacterial activities and cytotoxicity. Most of the synthesized compounds exhibited promising activities against the mc26230 strain of M. tuberculosis with MIC in the range of 5.1-11.9 µM and were non-cytotoxic against Vero cells. The conjugates lacking either isoniazid or quinoline core in their structural framework failed to inhibit the growth of M. tuberculosis; thus, further strengthening the proposed design of triads in the present study.
Collapse
Affiliation(s)
- Anu Rani
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, Punjab, India
| | - Matt D Johansen
- Institut de Recherche en Infectiologie (IRIM) de Montpellier, CNRS, UMR 9004 Université de Montpellier, France
| | - Françoise Roquet-Banères
- Institut de Recherche en Infectiologie (IRIM) de Montpellier, CNRS, UMR 9004 Université de Montpellier, France
| | - Laurent Kremer
- Institut de Recherche en Infectiologie (IRIM) de Montpellier, CNRS, UMR 9004 Université de Montpellier, France; INSERM, IRIM, 34293 Montpellier, France
| | - Paul Awolade
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa
| | - Oluwakemi Ebenezer
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa
| | - Parvesh Singh
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa
| | - Sumanjit
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, Punjab, India
| | - Vipan Kumar
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, Punjab, India.
| |
Collapse
|
4
|
Dorababu A. Pharmacology Profile of Recently Developed Multi‐Functional Azoles; SAR‐Based Predictive Structural Modification. ChemistrySelect 2020. [DOI: 10.1002/slct.202000294] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Atukuri Dorababu
- Department of Studies in ChemistrySRMPP Govt. First Grade College Huvinahadagali 583219, Karnataka India
| |
Collapse
|
5
|
Dragostin I, Dragostin OM, Samal SK, Dash S, Tatia R, Dragan M, Confederat L, Ghiciuc CM, Diculencu D, Lupușoru CE, Zamfir CL. New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation. Eur J Pharm Sci 2019; 137:104974. [PMID: 31252051 DOI: 10.1016/j.ejps.2019.104974] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 06/10/2019] [Accepted: 06/25/2019] [Indexed: 02/07/2023]
Abstract
Tuberculostatic drugs are the most common drug groups with global hepatotoxicity. Awareness of potentially severe hepatotoxic reactions is vital, as hepatic impairment can be a devastating and often fatal condition. The treatment problems that may arise, within this class of medicines, are mainly of two types: adverse reactions (collateral, toxic or hypersensitive reactions) and the initial or acquired resistance of Mycobacterium tuberculosis to one or more antituberculosis drugs. Prevention of adverse reactions, increase treatment adherence and success rates, providing better control of tuberculosis (TB). In this regard, obtaining new drugs with low toxicity and high tuberculostatic potential is essential. Thus, in this work, we have designed or synthesized new derivatives of isoniazid (INH), such as new Isonicotinoylhydrazone (INH-a, INH-b and INH-c). These derivatives demonstrated good biocompatibility, antimicrobial property similar to that of parent isoniazid and last but not least, a significantly improved Pharmacotoxicological profile compared to that of isoniazid.
Collapse
Affiliation(s)
- Ionut Dragostin
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Histology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Oana M Dragostin
- Dunarea de Jos University of Galati, Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, 47 Domneasca Str., Galati, Romania.
| | - Sangram Keshari Samal
- Laboratory of Biomaterials and Regenerative Medicine for Advanced Therapies, Materials Research Centre, Indian Institute of Science Bangalore, 560 012, Karnataka, India; Laboratory of Biomaterials and regenerative Medicine for Advanced Therapies, Indian Council of Medical Research-Regional Medical Research Centre, Bhubaneswar 751 023, Odisha, India
| | - Saumya Dash
- Laboratory of Biomaterials and Regenerative Medicine for Advanced Therapies, Materials Research Centre, Indian Institute of Science Bangalore, 560 012, Karnataka, India
| | - Rodica Tatia
- Romanian National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, 060031 Bucharest, Romania
| | - Maria Dragan
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Pharmacy, 16 Universitatii Str., 700115, Iasi, Romania
| | - Luminița Confederat
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Microbiology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Cristina M Ghiciuc
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Pharmacology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Daniela Diculencu
- Clinical Pneumophysiology Hospital, Medical Analysis Laboratory, Iasi, Romania
| | - Cătălina E Lupușoru
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Pharmacology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Carmen L Zamfir
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Histology, 16 Universitatii Str., 700115, Iasi, Romania
| |
Collapse
|
6
|
Synthesis, biological evaluation and computational study of novel isoniazid containing 4H-Pyrimido[2,1-b]benzothiazoles derivatives. Eur J Med Chem 2019; 177:12-31. [PMID: 31129451 DOI: 10.1016/j.ejmech.2019.05.028] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2017] [Revised: 03/23/2019] [Accepted: 05/07/2019] [Indexed: 12/17/2022]
Abstract
Synthesis of novel and potent hit molecules has an eternal demand. It is our continuous study to search novel bioactive hit molecules and as a part of this, a series of novel N'-isonicotinoyl-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carbohydrazide analogs (5a-5n) were synthesized with good yields by the conventional method. The various novel compounds have been characterized and identified by many analytical technique such as IR, 1H NMR, 13C NMR, mass spectral analysis, and elemental analysis. All the synthetic analogs (5a-5n) are evaluated for their in vitro antibacterial and anti-mycobacterial activities against different bacterial strains. Molecular docking and Molecular dynamics studies were helped in revealing the mode of action of these compounds through their interactions with the active site of the Mycobacterium tuberculosis enoyl reductase (InhA) enzyme. The calculated ADMET descriptors for the synthesized compounds validated good pharmacokinetic properties, confirming that these compounds could be used as templates for the development of new Anti-mycobacterial agents.
Collapse
|
7
|
|
8
|
Fernandes GFDS, Salgado HRN, Santos JLD. Isoniazid: A Review of Characteristics, Properties and Analytical Methods. Crit Rev Anal Chem 2017; 47:298-308. [PMID: 28080136 DOI: 10.1080/10408347.2017.1281098] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Isoniazid is a synthetic antimicrobial and one of the most important first-line drugs used in the treatment of tuberculosis. Since it was introduced in the therapy in 1952, the drug remains at the front line of the antituberculosis treatment mainly due to its potency and high selectivity against Mycobacterium tuberculosis. Pharmaceutical analysis and therapeutic drug monitoring of isoniazid in both, pharmaceuticals and biological samples, plays an important role to comprehend aspects regarding to bioavailability, bioequivalence and therapeutic monitoring during patients following-up. In the last case, validated and simple methods are extremely useful for Public Healthy in order to guarantee the drug efficacy, safety and reduce the tuberculosis resistance. Among the available analytical tools, HPLC-based methods coupled to ultraviolet or mass spectroscopy are the most widely used techniques to quantify isoniazid. Therefore, this review highlights the main analytical methods reported in the literature for determination of isoniazid focusing in HPLC-based methods.
Collapse
Affiliation(s)
- Guilherme Felipe Dos Santos Fernandes
- a Institute of Chemistry, São Paulo State University (UNESP) , Araraquara , Brazil.,b School of Pharmaceutical Sciences , São Paulo State University (UNESP) , Araraquara , Brazil
| | | | - Jean Leandro Dos Santos
- a Institute of Chemistry, São Paulo State University (UNESP) , Araraquara , Brazil.,b School of Pharmaceutical Sciences , São Paulo State University (UNESP) , Araraquara , Brazil
| |
Collapse
|
9
|
Firmino GSS, de Souza MVN, Pessoa C, Lourenco MCS, Resende JALC, Lessa JA. Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents. Biometals 2016; 29:953-963. [DOI: 10.1007/s10534-016-9968-7] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2016] [Accepted: 08/28/2016] [Indexed: 02/06/2023]
|
10
|
Costa VM, Souza MCMD, Fechine PBA, Macedo AC, Gonçalves LRB. NANOBIOCATALYTIC SYSTEMS BASED ON LIPASE-Fe3O4 AND CONVENTIONAL SYSTEMS FOR ISONIAZID SYNTHESIS: A COMPARATIVE STUDY. BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING 2016. [DOI: 10.1590/0104-6632.20160333s20150137] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
11
|
Chans GM, Nieto-Camacho A, Ramírez-Apan T, Hernández-Ortega S, Álvarez-Toledano C, Gómez E. Synthetic, Spectroscopic, Crystallographic, and Biological Studies of Seven-Coordinated Diorganotin(IV) Complexes Derived from Schiff Bases and Pyridinic Carboxylic Acids. Aust J Chem 2016. [DOI: 10.1071/ch15344] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The synthesis and characterisation of diorganotin(iv) monomeric derivatives of pyridine Schiff bases and pyridinic carboxylic acids are reported. All complexes were characterised by mass spectrometry, elemental analyses, IR spectra, and multinuclear NMR analyses. Among them, complexes 5a, 5d, 5e, 5g, and 6a were also confirmed by X-ray crystallography diffraction analyses, which led to establishing that the tin atom is seven-coordinated and has a distorted pentagonal–bipyramidal coordination environment in the solid state and also revealed that both ligands occupy the equatorial positions and the organic substituents the axial positions. The antioxidant activity of the synthetic derivatives towards 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) as well as the thiobarbituric acid reactive substances (TBARS) assay were determined, and were compared with standard antioxidants, showing a dose-dependent activity in both cases. A prominent response was obtained depending on the substituent. The anti-inflammatory activity was also evaluated on a 12-O-tetradecanoylphorbol-13-acetate (TPA) model of induced acute inflammation. The results of the biological tests are discussed in terms of structural characteristics.
Collapse
|
12
|
Kumar D, Khare G, Beena B, Kidwai S, Tyagi AK, Singh R, Rawat DS. Novel isoniazid–amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation. MEDCHEMCOMM 2015. [DOI: 10.1039/c4md00288a] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A series of isoniazid–amidoether derivatives was synthesized and screened for their antimycobacterial activity in vitro and in vivo.
Collapse
Affiliation(s)
- Deepak Kumar
- Department of Chemistry
- University of Delhi
- Delhi-110007
- India
| | - Garima Khare
- Department of Biochemistry
- University of Delhi South Campus
- New Delhi-110021
- India
| | - Beena Beena
- Department of Chemistry
- University of Delhi
- Delhi-110007
- India
| | - Saqib Kidwai
- Translational Health Science and Technology Institute
- Vaccine and Infectious Disease Research Centre
- Gurgaon
- India
| | - Anil K. Tyagi
- Department of Biochemistry
- University of Delhi South Campus
- New Delhi-110021
- India
| | - Ramandeep Singh
- Translational Health Science and Technology Institute
- Vaccine and Infectious Disease Research Centre
- Gurgaon
- India
| | - Diwan S. Rawat
- Department of Chemistry
- University of Delhi
- Delhi-110007
- India
| |
Collapse
|
13
|
Vanucci-Bacqué C, Carayon C, Bernis C, Camare C, Nègre-Salvayre A, Bedos-Belval F, Baltas M. Synthesis, antioxidant and cytoprotective evaluation of potential antiatherogenic phenolic hydrazones. A structure–activity relationship insight. Bioorg Med Chem 2014; 22:4269-76. [DOI: 10.1016/j.bmc.2014.05.034] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Revised: 05/12/2014] [Accepted: 05/14/2014] [Indexed: 01/30/2023]
|